Meanwhile, according to a 2026 study, patients in the dataset who took Wegovy were 4.74 times more likely to develop ION (Ischemic optic neuropathy) than those who took another brand of GLP-1 drugs
But affordability means nothing without reliability
This benefit makes it a valuable option for doctors and patients, especially since obesity is a common disease worldwide
We have a very elaborate and rigorous system to test medicines before theyre allowed to be used in patients
The lawsuit alleges the same type of failure to warn of side effects such as Gastroparesis, Stomach Paralysis, Ileus, Gallbladder issues, and Gastric Intestinal Obstruction
Your doctor can send it over to us for you, you can send it through our website or email, or just bring it with you